Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Vector-mediated drug delivery to the brain.

J Temsamani¹, C Rousselle, A R Rees

¹Syntem, Parc Scientifique Georges Besse, 30000 Nîmes, France. Jtemsamani@syntem.com

Expert Opinion on Biological Therapy

|December 1, 2001

Summary

The aging population increases brain disease risk, but the blood-brain barrier (BBB) blocks drug delivery. This review explores strategies, focusing on vector-mediated approaches, to improve central nervous system (CNS) therapeutics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to "Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results" [Int. J. Hyg. Environ. Health 248 (2023) 114097].

International journal of hygiene and environmental health·2023

Same author

A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe.

Archives of toxicology·2023

Same author

Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results.

International journal of hygiene and environmental health·2022

Same author

Is there an optimal sampling time and number of samples for assessing exposure to fast elimination endocrine disruptors with urinary biomarkers?

The Science of the total environment·2020

Same author

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy.

The AAPS journal·2020

Same author

Target engagement and intracellular delivery of mono- and bivalent LDL receptor-binding peptide-cargo conjugates: Implications for the rational design of new targeted drug therapies.

Journal of controlled release : official journal of the Controlled Release Society·2019

Area of Science:

Neuroscience
Pharmacology
Biomedical Engineering

Background:

The aging global population is associated with increased prevalence of neurodegenerative diseases, brain cancers, and infections.
The blood-brain barrier (BBB) significantly restricts the entry of potential therapeutic agents into the central nervous system (CNS).
The BBB's impermeability is due to tight junctions in brain capillary endothelial cells and low endocytic activity, preventing passage of polar and lipid-insoluble substances.

Purpose of the Study:

To review strategies for enhancing drug delivery across the blood-brain barrier (BBB).
To highlight the challenges in developing safe and effective CNS drug delivery systems.
To emphasize vector-mediated strategies for overcoming BBB limitations.

Main Methods:

Related Experiment Videos

Literature review of existing and emerging drug delivery strategies for the CNS.
Focus on vector-mediated approaches for enhanced drug transport across the BBB.
Analysis of the mechanisms and efficacy of different delivery systems.

Main Results:

The BBB poses a major obstacle for CNS drug development.
Various strategies are being explored to facilitate therapeutic molecule passage across the BBB.
Vector-mediated strategies show promise for targeted and efficient drug delivery.

Conclusions:

Overcoming the BBB is critical for treating CNS disorders.
Developing effective drug delivery systems is an ongoing challenge.
Vector-mediated strategies represent a key area of research for improving CNS therapeutics.